
Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives
Author(s) -
Bobeck S. Modjtahedi,
Tiffany Luong,
Stephan Chiu,
Tavé van Zyl,
Jane C. Lin,
Donald S. Fong
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s228618
Subject(s) - medicine , macular degeneration , visual acuity , ophthalmology , glaucoma , subgroup analysis , choroidal neovascularization , pharmacy , bevacizumab , chemotherapy , confidence interval , family medicine
To characterize the visual outcomes and the treatment course of patients with exudative age-related macular degeneration (AMD) based on ocular hypotensive use.